Improving Breast Cancer Diagnosis and Treatment
The BCSC research approach is translational – focusing on rapid movement of research findings from bench to bedside. Our mandate to researchers is to improve patient outcomes by accelerating the delivery of and access to novel therapies.
Our research is improving the lives of breast cancer patients through the development of precision oncology treatments, and new diagnostic tests – like a simple blood test that will detect the presence of some types of breast cancers.
The aim of precision oncology, also known as personalized medicine is to provide more targeted therapies for patients. Receiving an accurate diagnosis, avoiding unnecessary treatments such as chemotherapy and knowing how a patient will respond to their treatment before it begins offers new hope to patients and their families.
These are game-changing advancements – new tests for early detection and the development of more personalized treatments are making real differences for breast cancer patients and their families.